Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non‐small cell lung cancer patients
Authors:
- 1 July 2017
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 56 (12) , 2558-2565
Abstract
Lasp2, as well as Lasp1, is a member of the LIM‐protein subfamily of the nebulin group characterized by the combined presence of LIM and SH3 domains. Lasp1 and Lasp2 are highly conserved in their LIM, nebulin‐like, and SH3 domains but differ significantly at their linker regions. Lasp1 had been described as an oncogenic protein that was highly expressed in diverse cancer types and facilitated tumor proliferation, invasion, and metastasis process. However, unlike Lasp1, little is known about the functions of Lasp2. In the present study, using immunohistochemistry, we found that Lasp2 expression was significantly correlated with histological type (P = 0.012), advanced TNM stage (P = 0.024), positive regional lymph node metastasis (P = 0.035), and poor overall survival (P = 0.001). Would healing assay and transwell assay results indicated that Lasp2 promoted tumor migration and invasion in NSCLC cells. Furthermore, Lasp2 facilitated Snail expression and inhibited Zo‐1. The levels of phosphorylated FAK (Tyr397 and Tyr925) were obviously increased after overexpressing Lasp2 and were downregulated by transfecting Lasp2‐siRNA. FAK inhibitor counteracted upregulating Snail expression and downregulating of Zo‐1 expression induced by Lasp2 overexpression. Taken together, Lasp2 may facilitate tumor migration and invasion of NSCLCs through FAK‐Snail/Zo‐1 signaling pathway. Lasp2 may be a potential prognostic predictor of NSCLC patients.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (201421044)
- National Natural Science Foundation of China (81402520, 81472805, 81602012)
This publication has 31 references indexed in Scilit:
- Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survivalClinical Proteomics, 2016
- LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signalingScientific Reports, 2016
- An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker proteinOncotarget, 2014
- Overexpression of LIM and SH3 Protein 1 Leading to Accelerated G2/M Phase Transition Contributes to Enhanced Tumourigenesis in Oral CancerPLOS ONE, 2013
- Ectopic expression of LIM‐nebulette (LASP2) reveals roles in cell migration and spreadingCell Motility, 2008
- The LIM and SH3 domain protein family: structural proteins or signal transducers or both?Molecular Cancer, 2008
- Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisationBritish Journal of Cancer, 2007
- Linker region of nebulin family members plays an important role in targeting these molecules to cellular structuresCell and tissue research, 2006
- Zyxin Interacts with the SH3 Domains of the Cytoskeletal Proteins LIM-nebulette and Lasp-1Journal of Biological Chemistry, 2004
- Seated postural hypotension is common among older inpatientsClinical Autonomic Research, 2003